openai.com·Feb 5, 2026
An autonomous lab using OpenAI's GPT-5 and Ginkgo Bioworks' automation reduced cell-free protein synthesis costs by 40% through closed-loop experimentation.
For a professional interested in AI and LLMs, the key insight is that integrating advanced language models like GPT-5 with automation technology in biotechnology can significantly optimize processes and reduce costs, as demonstrated by a 40% cost reduction in cell-free protein synthesis. This highlights the potential for cross-industry applications of AI to drive efficiency and innovation.